[1]纪东华.卡托普利对冠心病介入治疗患者心室重构及炎性因子的影响[J].医学信息,2019,(17):137-138.[doi:10.3969/j.issn.1006-1959.2019.17.045]
 JI Dong-hua.Effects of Captopril on Ventricular Remodeling and Inflammatory Factors in Patients with Coronary Heart Disease Undergoing Interventional Therapy[J].Medical Information,2019,(17):137-138.[doi:10.3969/j.issn.1006-1959.2019.17.045]
点击复制

卡托普利对冠心病介入治疗患者心室重构及炎性因子的影响()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2019年17期
页码:
137-138
栏目:
药物与临床
出版日期:
2019-09-01

文章信息/Info

Title:
Effects of Captopril on Ventricular Remodeling and Inflammatory Factors in Patients with Coronary Heart Disease Undergoing Interventional Therapy
文章编号:
1006-1959(2019)17-0138-02
作者:
纪东华
佳木斯市中心医院心内科,黑龙江 佳木斯 154002
Author(s):
JI Dong-hua
Department of Cardiology,Jiamusi Central Hospital,Jiamusi 154002,Heilongjiang,China
关键词:
卡托普利经皮冠状动脉介入术冠心病心室重构
Keywords:
Key words:CaptoprilPercutaneous coronary interventionCoronary heart diseaseVentricular remodeling
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2019.17.045
文献标志码:
A
摘要:
目的 探讨卡托普利对冠心病(CHD)介入治疗患者心室重构及炎性因子的影响。方法 收集我院自2017年7月~2018年8月收治的72例接受经皮冠状动脉介入(PCI)治疗的CHD患者,按随机数字表法分为对照组和观察组,各36例。对照组术后采取常规基础治疗,观察组在对照组基础上联合卡托普利治疗,比较两组治疗前后左心室收缩末期容积(LVESV)、左室射血分数(LVEF)及血清肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)水平变化情况。结果 治疗后,观察组LVEDV为(100.50±5.42)ml、LVESV为(51.05±4.11)ml,低于对照组的(110.84±7.80)ml、(64.73±5.47)ml,观察组LVEF为(60.54±4.28)%,高于对照组的(51.62±4.01)%(P<0.05);观察组血清TNF-α、IL-6水平低于对照组(P<0.05)。结论 卡托普利能够有效减轻冠心病介入术后患者机体炎症反应,逆转心室重构,改善预后。
Abstract:
Abstract:Objective To investigate the effects of captopril on ventricular remodeling and inflammatory factors in patients with coronary heart disease (CHD).Methods 72 patients with CHD who underwent percutaneous coronary intervention (PCI) from July 2017 to August 2018 were enrolled. The patients were divided into control group and observation group according to the random number table, 36 cases for each group. The control group received routine basic treatment after operation. The observation group was treated with captopril on the basis of the control group. The left ventricular end-systolic volume (LVESV), left ventricular ejection fraction (LVEF) and serum tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels were compared before and after treatment.Results After treatment, the LVEDV of the observation group was (100.50±5.42) ml, and the LVESV was (51.05±4.11) ml, which was lower than that of the control group (110.84±7.80) ml, (64.73±5.47) ml, and the observation group LVEF was (60.54±4.28)% was higher than that of the control group (51.62±4.01)% (P<0.05); the serum levels of TNF-α and IL-6 in the observation group were lower than those in the control group (P<0.05).Conclusion Captopril can effectively alleviate the inflammatory response of patients with coronary heart disease after intervention, reverse ventricular remodeling and improve prognosis.

参考文献/References:

[1]相琳,罗丹,杨伟,等.高龄冠心病患者介入治疗远期预后分析[J].中华老年心脑血管病杂志,2018,20(3):247-249. [2]张东凤,吕树铮,宋现涛,等.炎性因子与轻中度冠状动脉狭窄患者斑块形态学特征的相关性研究[J].中国介入心脏病学杂志,2016,24(10):569-574. [3]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会组织专家组.中国经皮冠状动脉介入治疗指南(2016)[J].中华心血管病杂志,2016,44(5):382-400. [4]李康妮,韩明华.外周血管内皮功能、炎症因子与冠状动脉粥样硬化性心脏病的关系[J].岭南心血管病杂志,2015,21(1):24-27,69. [5]卫娇娜,杨睿海,王永进,等.PCI术后支架内再狭窄患者血清中谷氨酰转移酶及C反应蛋白与血管新生、炎症反应的相关性[J].海南医学院学报,2017,23(10):1344-1347.

相似文献/References:

[1]郑 磊.美托洛尔联合卡托普利对慢性心衰患者心肌重构及心功能的影响分析[J].医学信息,2018,(03):130.[doi:10.3969/j.issn.1006-1959.2018.03.045]
 ZHENG Lei.Effect of Metoprolol Combined with Captopril on Myocardial Remodeling and Cardiac Function in Patients with Chronic Heart Failure[J].Medical Information,2018,(17):130.[doi:10.3969/j.issn.1006-1959.2018.03.045]
[2]王建强,刘 瑜,张牧秋,等.房颤伴ACS患者经皮冠状动脉介入术后抗栓研究[J].医学信息,2019,(14):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]
 WANG Jian-qiang,LIU Yu,ZHANG Mu-qiu,et al.Study on Antithrombotic after Percutaneous Coronary Intervention in Patients with Atrial Fibrillation and ACS[J].Medical Information,2019,(17):35.[doi:10.3969/j.issn.1006-1959.2019.14.013]

更新日期/Last Update: 2019-09-01